RTV Tablet

Introduction

RTV Tablet 20 mg is a potent statin medication used to lower cholesterol levels and reduce the risk of cardiovascular events. It is part of the class of drugs known as HMG-CoA reductase inhibitors, which help manage hyperlipidemia by reducing the amount of cholesterol produced by the liver.

Uses

RTV Tablet 20 mg is primarily used for:

Lowering elevated total cholesterol, LDL cholesterol, and triglycerides.
Raising HDL cholesterol (the "good" cholesterol).
Reducing the risk of cardiovascular events such as heart attack, stroke, and angina in patients with a history of cardiovascular disease or at high risk.
Managing dyslipidemia in patients with conditions such as familial hypercholesterolemia.

Brand Name	RTV
Type	Tablet
Weight	20 mg
Generic	Rosuvastatin Calcium
Manufacturer	Delta Pharma Ltd.
Available in	English বাংলা

Mechanism of Action

RTV Tablet 20 mg works by inhibiting HMG-CoA reductase, an enzyme crucial for the biosynthesis of cholesterol in the liver. By blocking this enzyme, Rosuvastatin reduces the production of cholesterol, leading to a decrease in circulating levels of LDL cholesterol and triglycerides, and an increase in HDL cholesterol.

How Long Does It Take to Work?

Patients may start to see improvements in cholesterol levels within 2 weeks of starting Rosuvastatin. The maximum effect is generally observed after 4 to 6 weeks of continuous therapy.

Absorption

Rosuvastatin is well-absorbed after oral administration, with peak plasma concentrations occurring approximately 5 hours post-dose. The drug has high bioavailability, but its absorption can be slightly reduced with food.

Route of Elimination

Rosuvastatin is predominantly eliminated through the feces (approximately 90%) after hepatic metabolism. The remaining amount is excreted in the urine. The drug undergoes extensive first-pass metabolism in the liver.

Dosage

Heterozygous Familial Hypercholesterolemia in Pediatric Patients (10 to 17 years of age): The usual dose range of Rosuvastatin is 5-20 mg/day; the maximum recommended dose is 20 mg/day (doses greater than 20 mg have not been studied in this patient population). Doses should be individualized according to the recommended goal of therapy. Adjustments should be made at intervals of 4 weeks or more.

Very High Cholesterol and High Risk of Ml or Stroke: 40 mg once daily.

Homozygous Familial Hypercholesterolemia: The recommended starting dose of Rosuvastatin is 20 mg once daily. Response to therapy should be estimated from preapheresis LDL-C levels.

Dosage in Asian Patients: Initiation of Rosuvastatin therapy with 5 mg once daily should be considered for Asian patients

Use with Cyclosporine, Lopinavir/Ritonavir or Atazanavir/Ritonavir: In patients taking Cyclosporine, the dose of Rosuvastatin should be limited to 5 mg once daily. In patients taking a combination of Lopinavir and Ritonavir or Atazanavir and Ritonavir, the dose of Rosuvastatin should be limited to 10 mg once daily.

Concomitant Lipid-Lowering Therapy: The risk of skeletal muscle effects may be enhanced when Rosuvastatin is used in combination with Niacin or Fenofibrate; a reduction in Rosuvastatin dosage should be considered in this setting. Combination therapy with Gemfibrozil should be avoided because of an increase in Rosuvastatin exposure with concomitant use; if Rosuvastatin is used in combination with Gemfibrozil, the dose of Rosuvastatin should be limited to 10 mg once daily.

Dosage in Patients with Severe Renal Impairment: For patients with severe renal impairment (ClCr<30 mL/min/1.73 m²) not on hemodialysis, dosing of Rosuvastatin should be started at 5 mg once daily and not exceed 10 mg once daily.

The typical dosage for adults is:

Initial dose: 10 to 20 mg once daily.
Maintenance dose: 5 to 40 mg once daily, depending on the patient's cholesterol levels and risk factors.
Dosage adjustments should be made based on therapeutic response and tolerability.

Dosage for children aged 10-17 years: 5 to 20 mg once daily.

Administration

Rosuvastatin should be taken orally, with or without food. It is usually taken once daily, at the same time each day to maintain consistent drug levels. The medication can be taken in the morning or evening as prescribed.

Side Effects

Common side effects include:

Headache
Muscle pain or weakness
Abdominal pain
Nausea

Serious side effects may include:

Rhabdomyolysis (severe muscle breakdown)
Hepatic enzyme elevation
Allergic reactions

Toxicity

Overdose of Rosuvastatin may lead to severe muscle toxicity, liver damage, and gastrointestinal symptoms. In cases of overdose, supportive care and monitoring are essential, and specific treatment may be required based on the symptoms presented.

Precautions

Use with caution in patients with:

History of liver disease
Renal impairment
Uncontrolled thyroid disease
Alcohol abuse

Periodic monitoring of liver enzymes and muscle symptoms is recommended during treatment.

Interaction

Rosuvastatin may interact with other drugs such as:

Cyclosporine, which can increase Rosuvastatin levels
Antacids, which may reduce Rosuvastatin absorption
Other lipid-lowering agents, which may increase the risk of side effects

Disease Interaction

Special considerations should be given to patients with:

Active liver disease or unexplained persistent elevations of liver enzymes
Severe renal impairment
History of muscle disorders or statin intolerance

Drug Interaction

Drug interactions may include:

Increased risk of myopathy with other statins or fibrates
Potential interaction with warfarin and other anticoagulants

Food Interactions

Food interactions are minimal, but high-fat meals may reduce the rate of absorption slightly. It is generally recommended to maintain a consistent dietary regimen during treatment.

Pregnancy Use

Rosuvastatin is classified as a Category X drug for pregnancy, meaning it is contraindicated due to potential harm to the fetus. Women of childbearing age should use effective contraception while on this medication.

Lactation Use

It is not known whether Rosuvastatin is excreted in breast milk. Due to potential risks, breastfeeding is generally not recommended while using this medication. Consult a healthcare provider for alternatives if necessary.

Acute Overdose

In cases of acute overdose, seek medical attention immediately. Treatment is supportive and symptomatic, and may involve monitoring for liver or muscle damage and supportive care.

Contraindication

Rosuvastatin is contraindicated in:

Patients with active liver disease
Patients with hypersensitivity to Rosuvastatin or any component of the formulation
Pregnant women and women who are breastfeeding

Use Direction

Follow the prescribed dosage and administration guidelines. Do not adjust the dose without consulting a healthcare provider. Regular monitoring and follow-up are important to ensure the efficacy and safety of the treatment.

Storage Conditions

Store Rosuvastatin at room temperature, away from moisture and heat. Keep the medication in its original container, tightly closed, and out of reach of children.

Volume of Distribution

The volume of distribution for Rosuvastatin is approximately 134 L, indicating extensive distribution throughout the body tissues.

Half Life

The half-life of Rosuvastatin is approximately 19 hours, which supports once-daily dosing.

Clearance

Rosuvastatin is cleared primarily through the liver. Renal clearance accounts for a minor portion of the total clearance, with adjustments needed in severe renal impairment.

See in details version RTV Tablet 20 mg also RTV Tablet 20 mg in bangla